1-3 of 3
Nabih Maslah
Close
Sort by
Journal Articles

Single-cell analysis reveals selection of TP53 -mutated clones after MDM2 inhibition

Nabih Maslah, Emmanuelle Verger, Stéphane Giraudier, Mathias Chea, Ronald Hoffman, John Mascarenhas, Bruno Cassinat, Jean-Jacques Kiladjian
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2813–2823.
https://doi.org/10.1182/bloodadvances.2021005867
Published: 2022
Includes: Supplemental data
Journal Articles

Adenylate kinase 2 expression and addiction in T-ALL

Nabih Maslah, Mehdi Latiri, Vahid Asnafi, Mélanie Féroul, Nawel Bedjaoui, Thomas Steimlé, Emmanuelle Six, Els Verhoyen, Elizabeth Macintyre, Chantal Lagresle-Peyrou, Ludovic Lhermitte, Guillaume P. Andrieu
Journal: Blood Advances
Blood Adv (2021) 5 (3): 700–710.
https://doi.org/10.1182/bloodadvances.2020002700
Published: 2021
Includes: Supplemental data
Journal Articles

Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses

Clinical Trials & Observations
Pierre-Edouard Debureaux, Bruno Cassinat, Juliette Soret-Dulphy, Barbara Mora, Emmanuelle Verger, Nabih Maslah, Aurelie Plessier, Pierre-Emmanuel Rautou, Isabelle Ollivier-Hourman, Victor De Ledinghen, Odile Goria, Christophe Bureau, Claudia Siracusa, Dominique Valla, Stephane Giraudier, Francesco Passamonti, Jean-Jacques Kiladjian
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3708–3715.
https://doi.org/10.1182/bloodadvances.2020002414
Published: 2020
Includes: Supplemental data